Immunoreactivity of proliferating cell nuclear antigen in transitional cell carcinoma of urinary bladder
Biomedica. 2008; 24 (Jan.-Jun.): 46-49
em Inglês
| IMEMR
| ID: emr-85994
ABSTRACT
This is a descriptive study designed to evaluate Proliferating cell nuclear antigen [PCNA] in transitional cell carcinoma. A total of fifty per urethra resected bladder tumour samples [TUR BT] were collected from Mayo Hospital and Services Hospital, Lahore and processed for H and E and PCNA stain. The grading of tumours were made on H and E stain. While Proliferating cell nuclear antigen labeling index was recorded for each case. The mean PCNA labeling index was significantly higher in grade III when compared with tumours of grade II. [p < 0.001] carcinoma. Similarly mean PCNA labeling index was significantly higher [p < 0.05] in patients having duration of symptoms up to 3 month when compared with the patients having longer duration of symptoms. The mean PCNA labeling index had significantly higher value in high grade tumours as compared to low grade tumours [p < 0.001]. Although determination of PCNA labeling index is costly yet it has significant role in tumour grading
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Fatores de Tempo
/
Neoplasias da Bexiga Urinária
/
Carcinoma de Células de Transição
/
Seguimentos
Limite:
Humanos
Idioma:
Inglês
Revista:
Biomedica
Ano de publicação:
2008
Similares
MEDLINE
...
LILACS
LIS